The government has also approved the procedure for reporting the use of Covit-19 self-examination and the announcement of its results.
According to Resolution 28/2022 published in the Official Gazette this Tuesday, sales of this product will be limited to participating pharmacies.
The regulation, signed by Health Minister Carla Vizotti, establishes that users must inform pharmacies of the results of the test and that these businesses must submit relevant reports to the National Health Monitoring Organization (SNVS).
See you too
The third wave of the corona virus
Among the considerations of this measure are, “the key pillar of control measures is to reduce the likelihood of infection, to improve isolation measures of positive cases, to detect close contacts, and to access timely detection, therefore, in the event of an outbreak.”
In that direction, “the implementation of COVID-19 self-assessment testing cooperates with the decentralization process required to provide the best response to a situation affecting public health because they do not require very complex equipment or technology”.
The resolution, along with other points, indicates that if the diagnosis is positive or negative, the buyer should report it to health officials.
It will do so individually (pay attention to the barcode of each package) once it opens within 24 hours of being made.
If the product is purchased by an individual user at the participating pharmacy, the application report is always made at the same point of sale – either in person or over the phone – on a website or other means of creation.
If the test is obtained and / or used by a public or private entity, they should assign the health note responsible for the utility report and report the goal and results to the place of acquisition or, in case of failure, to the health authorities. Your jurisdiction.
/ Embedded Code Home /
/ End embed code /